Importantly, it has been proposed that the acquisition of the senescent phenotype occurs at the expense of an increased state of cell death readiness. This is due to the formation of stable complexes between anti-apoptotic BCL-2 guardians and BH3-only activators/sensitizers that ensure the survival of TIS cancer cells despite increased stress signaling [23–26]. Here, BCL2 is linked to cancer.